[18F]MK3328

MK-3328 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [18F]MK3328, covering 2014-02-05 to 2014-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Radiation Dosimetry, Biokinetics, and Effectiveness of [18F]MK3328 (MK-3328-001) [Phase 1]